NeuroSense Therapeutics Ltd.
NRSN$21M
Micro CapNASDAQPharmaceutical Preparations🇺🇸North AmericaHERZLIYA17 employees
Drugs in Pipeline
2
Phase 3 Programs
0
Upcoming Catalysts
0
Next Catalyst
None scheduled
Market Overview
Stock performance and key metrics
NRSN News
Catalyst Timeline
0 upcoming, 0 past
No catalysts found.
Drug Pipeline
PrimeC
Alzheimer Disease
Fixed dose combination Ciprofloxacin/Celecoxib
Amyotrophic Lateral Sclerosis
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
PrimeC | Phase 2 | Alzheimer Disease | - | - |
Fixed dose combination Ciprofloxacin/Celecoxib | Phase 2 | Amyotrophic Lateral Sclerosis | - | - |
Source: CatalystAlert database (ClinicalTrials.gov, SEC EDGAR)
Regulatory Approvals
Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply